An estimated 12 million people in the U.S. suffer from coronary artery disease; it is the No. 1 killer of Americans.

The most common symptom of coronary artery disease is angina, also known as chest pain. More than 7 million people in this country suffer with this crippling pain.

Coronary artery disease can lead to heart failure, a condition that affects more than 5 million Americans with over 500,000 new cases diagnosed each year.

Chances are that you or someone you know has been diagnosed with coronary artery disease or heart failure. It's frightening when you consider that these are serious conditions for which there are no cures. The good news is these diseases can be managed, and living a full and enjoyable life with the right treatment and healthy lifestyle is possible. EECP® therapy has been used extensively to eliminate or improve angina for many patients, particularly those with congestive heart failure. Many patients have reduced the need for nitroglycerin or eliminated use altogether.

Developed by Vasomedical, Inc., EECP® has been tested in multicenter, controlled, clinical studies, with positive medical results and a demonstrated quality of life improvement. Enhancing your life's rhythm is at the heart of EECP®. With Medicare coverage, there's one more good reason to ask your doctor if EECP® is the treatment for you.

EECP® treatment centers are located around the world.

Request information on EECP® centers located in the U.S.

Request information on international EECP® centers.

Or call 800.455.EECP® (3327) or 516.997.4600 outside the U.S.